Simple Summary
Dairy cows are most vulnerable to disease in the weeks around calving, when inflammation that should settle sometimes persists and contributes to metritis, mastitis and ketosis. Two linked molecules, ATP and adenosine, act as the body’s alarm and all-clear signals for inflammation, yet they remain little studied in cattle. This review matters because it unites the scattered bovine evidence, proposes that these signals work like a dimmer switch that fails to turn inflammation down in affected cows, and separates proven findings in cattle from assumptions drawn from mice and humans. It also outlines the experiments needed to test this idea. If confirmed, it could yield candidate markers and treatments, although their practical value for cow health, welfare and productivity would still need to be shown in field studies.
Abstract
Extracellular ATP and adenosine form a coupled signaling system that sets both the intensity and the duration of inflammation. ATP released from stressed or dying cells acts on P2 receptors as a danger signal, whereas adenosine produced from ATP by ectonucleotidases acts on P1 receptors to restrain immune cells and promote repair. This system is well mapped in rodents and humans but has received little systematic attention in cattle. In this review, we propose that the ATP–adenosine balance behaves as a rheostat for inflammatory resolution in the dairy cow, and that several bovine diseases can be read as failures of this rheostat to turn down. We assemble the bovine evidence in four areas: peripartal shifts in purinergic gene networks in liver and neutrophils; P2X receptor biology, including P2X7-independent inflammasome activation in bovine monocytes, P2X7-dependent killing of Mycobacterium bovis, P2X7R-linked pyroptosis in ketosis-associated endometritis and P2X1-dependent neutrophil extracellular trap formation; altered ectonucleotidase and adenosine deaminase activities in dictyocaulosis, eurytrematosis, fasciolosis and anaplasmosis (included as comparative evidence); and early biomarker work with serum and salivary adenosine deaminase. The evidence is still largely transcriptional, correlative or in vitro, and it does not always point in one direction. We therefore separate what has been shown in cattle from what is inferred from other species, define four ways in which the rheostat could fail, each with a measurable prediction, identify the experiments needed to test the rheostat model, and outline how purinergic receptors, ectoenzymes and release channels could become candidate therapeutic targets and biomarkers. The framework links peripartal metabolic stress to purinergic signaling and offers a testable route to earlier detection and more targeted control of inflammation-related disease in dairy cows.